Skip to content
CIFAR header logo
fr
menu_mobile_logo_alt
  • News
  • Events
    • Public Events
    • Invitation-only Meetings
  • Programs
    • Research Programs
    • Pan-Canadian AI Strategy
    • Next Generation Initiatives
    • Global Call for Ideas
  • People
    • Fellows & Advisors
    • CIFAR Azrieli Global Scholars
    • Canada CIFAR AI Chairs
    • AI Strategy Leadership
    • Solution Network Members
    • Leadership
  • Support Us
  • About
    • Our Story
    • CIFAR 40
    • Awards
    • Partnerships
    • Publications & Reports
    • Careers
    • Staff Directory
    • Equity, Diversity & Inclusion
  • fr
Report

CIFAR Roundtables on Cancer and the Dark Genome

By: Johnny Kung
29 Sep, 2022
September 29, 2022
Cancer-and-dark-genome_banner

In the past two decades, advances in genomic sequencing have led to significant leaps forward in our understanding of how genetic changes contribute to the development of cancer.

Major publicly-funded collaborative projects have generated valuable resources for the entire cancer research community. These resources have allowed researchers to develop new insights into how alterations in genetic pathways could lead to cancer.

Much of these existing resources and research are focused on “coding genes”, which encode for the proteins that constitute many of the functional and structural components of our cells. However, more than 98% of our genome is “noncoding”, and this “dark matter” of the genome has been shown to have important biological functions, controlling how genes are turned on or off. What is currently lacking is a comprehensive repository of all the different types of noncoding elements relevant to cancer, and more importantly, a systematic effort to understand the functional significance of genetic changes in the noncoding genome for cancer development.

On November 3, 2021, CIFAR organized a roundtable of international experts in the biology of the noncoding genome and cancer biology, as well as leaders of “Big Biology” programs. A broad consensus emerged that the field would be considerably advanced by the development of shared resources such as databases and new research tools and techniques. On April 26, 2022, a second roundtable was convened to discuss the potential scientific priorities and governance structure for a project to build these shared resources.

This report provides a brief introduction to the biology of the dark genome and highlights key insights that emerged from these two roundtables, including promising next steps for progress in this area.

This series of roundtables was made possible by the generous support of the MacMillan Family Foundation.

 

 

 

 

 

 

 

 

 


For more information, contact
Johnny Kung Senior Officer, Knowledge Mobilization and Publications, CIFAR

  • Follow Us

Related Articles

  • Accelerating Progress in Fungal Diagnostics
    October 20, 2021
  • COVID-19 may forever alter our microbiomes
    January 26, 2021
  • Obesity, heart disease, and diabetes may be communicable
    March 26, 2020
  • When antibiotics fail
    November 14, 2019

Support Us

CIFAR is a registered charitable organization supported by the governments of Canada, Alberta and Quebec, as well as foundations, individuals, corporations and Canadian and international partner organizations.

Donate Now
CIFAR header logo

MaRS Centre, West Tower
661 University Ave., Suite 505
Toronto, ON M5G 1M1 Canada

Contact Us
Media
Careers
Accessibility Policies
Supporters
Financial Reports
Subscribe

  • © Copyright 2023 CIFAR. All Rights Reserved.
  • Charitable Registration Number: 11921 9251 RR0001
  • Terms of Use
  • Privacy
  • Sitemap

Subscribe

Stay up to date on news & ideas from CIFAR.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.
Accept Learn more